ARROWHEAD PHARMACEUTICALS, INC.

Develops RNAi medicines to silence genes causing intractable cardiometabolic and pulmonary diseases.

ARWR | US

Overview

Corporate Details

ISIN(s):: US04280A1007
LEI:
Country:: United States of America
Address:: 177 E COLORADO BLVD, 91105 PASADENA
Website:: https://arrowheadpharma.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company that develops medicines to treat intractable diseases by silencing the genes that cause them. The company's core technology is its proprietary Targeted RNAi Molecule (TRiM™) platform, which utilizes RNA interference (RNAi) to induce rapid, deep, and durable suppression of specific target genes. Arrowhead's clinical pipeline is focused on a broad range of therapeutic areas, including cardiometabolic, pulmonary, neuromuscular, and liver diseases, such as hepatitis B and alpha-1 antitrypsin deficiency-associated liver disease. The company emphasizes accelerating the development of its innovative therapies from discovery to the clinic to address unmet patient needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all ARROWHEAD PHARMACEUTICALS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ARROWHEAD PHARMACEUTICALS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for ARROWHEAD PHARMACEUTICALS, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
OPKO HEALTH, INC. A biopharma and diagnostics firm offering novel therapies and full-service clinical lab testing.	United States of America	OPK
Opthea Ltd Biopharma that discontinued its wet AMD therapy after its lead drug failed Phase 3 trials.	United States of America	OPT
OPTUS Pharmaceutical Co., Ltd. Develops and manufactures ophthalmic solutions for dry eye, infections, and inflammation.	South Korea	131030
Opus Genetics, Inc. Developing gene therapies for inherited retinal diseases and other blinding conditions.	United States of America	IRD
ORAGENICS INC Biotech developing intranasal drugs for concussion and other brain disorders.	United States of America	OGEN
Oramed Pharmaceuticals Inc. Develops oral drug delivery systems to turn injectable drugs, like insulin, into oral therapies.	Israel	ORMP
ORASURE TECHNOLOGIES INC Develops and distributes point-of-care diagnostic tests and sample collection devices.	United States of America	OSUR
Orexo Develops pharmaceuticals & digital health for opioid use disorder in the US market.	Sweden	ORX
ORGANIGRAM GLOBAL INC. Licensed producer of indoor-grown cannabis and derived products for medical & recreational consumers.	United States of America	OGI
Organon & Co. A global healthcare company focused on women's health, biosimilars, and established brands worldwide.	United States of America	OGN